Merge PACS vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Merative
VS
by Tempus AI, Inc.

AI Verdict

Merge PACS is an enterprise-level imaging system that consolidates multi-modality data and integrates third-party AI applications across radiology and cardiology workflows. In contrast, Tempus ECG-AF is a highly specialized AI algorithm specifically designed to analyze 12-lead ECGs for predicting atrial fibrillation risk in a defined patient population. While both operate within the cardiology AI domain, Merge PACS offers a broad platform for imaging management and AI integration, whereas Tempus ECG-AF provides a targeted diagnostic insight.

Choose Merge PACS if…

Choose Merge PACS if your multi-site health system requires an enterprise-level imaging solution to consolidate diverse imaging data, streamline radiology and cardiology workflows, and seamlessly integrate third-party AI applications. This tool is ideal for organizations seeking a flexible, cloud-ready PACS that enhances diagnostic interpretation across multiple modalities and provides robust enterprise-wide image management.

View Merge PACS →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your cardiology or internal medicine practice aims to proactively identify elderly patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year. This AI-powered algorithm provides a specialized, FDA-cleared analysis of 12-lead ECGs, enabling earlier risk stratification and facilitating timely follow-up for eligible patients.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Merge PACS Tempus ECG-AF
Pricing Contact vendor Contact vendor
Deployment On-premise, Cloud, Hybrid Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Merge PACS

Merge PACS is designed with a strong focus on user experience for diagnostic interpretation, offering customizable worklists, fewer clicks for common tasks, and continuous workflow enhancements based on user feedback. Tempus ECG-AF, while seamlessly integrated, operates as a backend algorithm without a dedicated user interface, providing results within existing systems rather than offering direct interactive controls.

Clinical Value

Tempus ECG-AF

Tempus ECG-AF provides a specific, FDA-cleared, AI-driven predictive risk assessment for new-onset Atrial Fibrillation, directly impacting proactive patient management and prevention of AF-related complications. While Merge PACS enhances diagnostic workflows and efficiency across multiple imaging modalities, Tempus ECG-AF offers a more direct and quantifiable clinical outcome for a critical condition.

Pricing & Value

Tempus ECG-AF

Tempus ECG-AF explicitly details CMS reimbursement availability with specific CPT codes and a Medicare rate, providing a clear financial pathway for healthcare providers to recover costs or generate revenue. Merge PACS only states 'contact vendor' for pricing, offering no transparency on its financial value proposition.

Enterprise Readiness

Merge PACS

Merge PACS is explicitly an 'enterprise-level' system designed for multi-site health systems, offering broad integration with EMR/EHR, RIS, HIS, and VNA systems, along with flexible deployment options. Tempus ECG-AF, while integrated into healthcare facility systems, is a more specialized software solution with specific ECG device compatibility, not demonstrating the same breadth of enterprise-wide imaging management.

Innovation

Tempus ECG-AF

Tempus ECG-AF represents a cutting-edge innovation with its FDA-cleared, AI-based predictive algorithm for identifying AF risk from standard ECGs, trained on a massive dataset, offering a novel approach to proactive patient management. Merge PACS is innovative in its platform approach to integrate various third-party AI tools and advanced imaging features, but Tempus ECG-AF's specific predictive AI application for a critical clinical condition gives it a slight edge.

Support & Docs

Merge PACS

Merative (Merge PACS) offers a comprehensive support structure including 24/7 phone support, a dedicated user community, email support, and various documentation resources like user manuals and educational webinars. Tempus ECG-AF provides contact information for technical support and a document library but lacks the explicit 24/7 availability or community features.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Merge PACS Tempus ECG-AF
Product Name Merge PACS Tempus ECG-AF
Company Merative Tempus AI, Inc.
Primary Function Enterprise-level Picture Archiving and Communication System (PACS) that streamlines radiology workflows, consolidates imaging data, and integrates AI insights across multi-site health systems. It supports multi-modality diagnostic interpretation with flexible deployment options. FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Radiology Cardiology, Geriatrics, Internal Medicine
Key AI Functionality AI integration and readiness (single worklist access to 3rd party AI applications) AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months

Videos

Demos, reviews, and walkthroughs featuring Merge PACS and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Merge PACS is an enterprise-level system designed to integrate with EMR/EHR, RIS, HIS, and VNA systems, offering a single worklist for AI applications and customizable workflows across multiple specialties. Tempus ECG-AF integrates into healthcare facility systems and EHRs to deploy AI insights, specifically designed to work with existing ECG platforms without a dedicated user interface, using standard communication protocols.
Tempus ECG-AF identifies patients at increased risk of new-onset AF within 12 months, with a reported sensitivity of 31% and specificity of 92%, and a negative predictive value (NPV) of 95%. Its results are a risk notification, not a diagnosis, and must be interpreted with other diagnostic information and clinical history. Merge PACS enhances diagnostic workflows across multiple modalities, supporting features like synchronized priors scrolling for mammography and image fusion to aid interpretation.
Merge PACS is an enterprise-level solution for Cardiology and Radiology, designed for multi-site health systems to manage imaging data across various modalities and specialties, including mammography. Tempus ECG-AF is specifically for Cardiology, Geriatrics, and Internal Medicine, intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to identify increased risk of developing AF.
Merge PACS is described as generally intuitive and user-friendly, with customizable worklists and viewer capabilities designed to streamline daily reading. While some users note a steep learning curve for implementation, the system aims for efficiency and consistency. Tempus ECG-AF integrates into existing ECG platforms and EHRs, with its AI insights surfaced within current clinical workflows, suggesting a design that minimizes added complexity for clinicians.
Merge PACS features a security-conscious design with user authentication, role-based access controls, encryption of data at rest and in transit, and audit trails for monitoring and compliance. Tempus ECG-AF is HIPAA compliant, but the provided information does not detail specific advanced security or audit-trail features beyond that.
Merge PACS is an enterprise-level system built for multi-site health systems, designed to consolidate imaging data and integrate AI insights across various locations, offering centralized configuration and update options. Tempus ECG-AF is designed for scalable deployment across hospitals and outpatient settings, integrating into existing healthcare facility systems.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.